Title | Type | SJR | H index | Total Docs. (2020) | Total Docs. (3years) | Total Refs. (2020) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2020) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Drug Resistance Updates | journal | 4.010 Q1 | 132 | 27 | 52 | 6312 | 868 | 52 | 17.80 | 233.78 | |
2 | Biochimica et Biophysica Acta - Reviews on Cancer | journal | 3.435 Q1 | 159 | 105 | 192 | 16163 | 1866 | 190 | 10.07 | 153.93 | |
3 | Advances in Cancer Research | journal | 1.570 Q1 | 109 | 34 | 103 | 4898 | 609 | 13 | 5.98 | 144.06 | |
4 | Annual Review of Cancer Biology | book series | 5.657 Q1 | 36 | 44 | 70 | 5746 | 619 | 69 | 9.13 | 130.59 | |
5 | Blood Reviews | journal | 2.670 Q1 | 112 | 52 | 152 | 6428 | 1230 | 152 | 7.87 | 123.62 | |
6 | Recent Results in Cancer Research | book series | 0.186 Q4 | 63 | 55 | 81 | 6558 | 210 | 16 | 2.90 | 119.24 | |
7 | Cancer and Metastasis Reviews | journal | 2.555 Q1 | 167 | 87 | 176 | 10312 | 1487 | 169 | 7.94 | 118.53 | |
8 | Cancer Drug Discovery and Development | book series | 0.103 Q4 | 8 | 14 | 115 | 1651 | 49 | 7 | 0.59 | 117.93 | |
9 | Nature Reviews Cancer | journal | 19.575 Q1 | 505 | 88 | 370 | 8894 | 9218 | 202 | 18.59 | 101.07 | |
10 | NTP Technical Report on the Toxicity Studies Series | book series | 6 | 3 | 7 | 289 | 0 | 7 | 0.00 | 96.33 | ||
11 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.710 Q3 | 52 | 26 | 89 | 2460 | 300 | 85 | 3.84 | 94.62 | |
12 | Exploration of Targeted Anti-tumor Therapy | journal | 10 | 29 | 0 | 2706 | 0 | 0 | 0.00 | 93.31 | ||
13 | Cancer Treatment Reviews | journal | 4.278 Q1 | 164 | 106 | 345 | 9562 | 3879 | 341 | 11.50 | 90.21 | |
14 | Journal of Hematology and Oncology | journal | 4.305 Q1 | 144 | 163 | 440 | 14177 | 5901 | 436 | 14.91 | 86.98 | |
15 | Molecular Cancer | journal | 7.274 Q1 | 196 | 155 | 492 | 13169 | 11747 | 459 | 25.22 | 84.96 | |
16 | Healthbook TIMES Oncology Hematology | journal | 3 | 17 | 8 | 1427 | 0 | 8 | 0.00 | 83.94 | ||
17 | Critical Reviews in Oncology/Hematology | journal | 2.084 Q1 | 144 | 188 | 542 | 15644 | 3555 | 539 | 5.88 | 83.21 | |
18 | NAR Cancer | journal | 17 | 36 | 1 | 2962 | 0 | 0 | 0.00 | 82.28 | ||
19 | Journal of Mammary Gland Biology and Neoplasia | journal | 1.177 Q2 | 112 | 32 | 69 | 2548 | 219 | 67 | 2.53 | 79.63 | |
20 | Current Cancer Drug Targets | journal | 0.972 Q2 | 103 | 75 | 237 | 5949 | 734 | 219 | 3.13 | 79.32 | |
21 | Cancers | journal | 1.818 Q1 | 133 | 3843 | 2723 | 302766 | 17841 | 2686 | 6.25 | 78.78 | |
22 | Journal of Cancer Metastasis and Treatment | journal | 16 | 54 | 79 | 4118 | 193 | 78 | 2.44 | 76.26 | ||
23 | Expert Review of Anticancer Therapy | journal | 1.209 Q2 | 85 | 118 | 348 | 8783 | 1361 | 312 | 3.81 | 74.43 | |
24 | Ca-A Cancer Journal for Clinicians | journal | 62.937 Q1 | 211 | 45 | 118 | 3309 | 15845 | 79 | 130.62 | 73.53 | |
25 | Current Oncology Reports | journal | 1.595 Q1 | 77 | 122 | 299 | 8968 | 1451 | 298 | 4.80 | 73.51 | |
26 | European Journal of Cancer, Supplement | journal | 29 | 11 | 0 | 804 | 0 | 0 | 0.00 | 73.09 | ||
27 | Current Hematologic Malignancy Reports | journal | 1.299 Q2 | 44 | 46 | 194 | 3300 | 679 | 192 | 3.72 | 71.74 | |
28 | Oncology Reviews | journal | 1.637 Q1 | 31 | 28 | 52 | 1999 | 310 | 51 | 3.62 | 71.39 | |
29 | Hepatoma Research | journal | 14 | 85 | 43 | 6029 | 29 | 37 | 0.67 | 70.93 | ||
30 | Cancer journal (Sudbury, Mass.) | journal | 1.825 Q1 | 102 | 76 | 181 | 5317 | 634 | 161 | 2.96 | 69.96 | |
31 | Biologics: Targets and Therapy | journal | 0.948 Q2 | 47 | 12 | 49 | 833 | 192 | 49 | 4.50 | 69.42 | |
32 | Cellular oncology (Dordrecht) | journal | 1.698 Q1 | 58 | 81 | 165 | 5595 | 976 | 161 | 6.12 | 69.07 | |
33 | Cancer Biology and Medicine | journal | 1.517 Q1 | 62 | 76 | 160 | 5110 | 888 | 160 | 3.91 | 67.24 | |
34 | Current Treatment Options in Oncology | journal | 1.457 Q1 | 66 | 97 | 242 | 6481 | 1179 | 240 | 4.83 | 66.81 | |
35 | Current Cancer Therapy Reviews | journal | 0.128 Q4 | 17 | 34 | 51 | 2240 | 19 | 44 | 0.28 | 65.88 | |
36 | Cancer Letters | journal | 2.470 Q1 | 216 | 425 | 1401 | 27587 | 11272 | 1387 | 7.68 | 64.91 | |
37 | Seminars in Radiation Oncology | journal | 1.761 Q1 | 103 | 40 | 129 | 2575 | 678 | 118 | 5.45 | 64.38 | |
38 | Trends in Cancer | journal | 4.175 Q1 | 90 | 117 | 276 | 7533 | 2548 | 268 | 7.60 | 64.38 | |
39 | MedComm | journal | 25 | 38 | 0 | 2425 | 0 | 0 | 0.00 | 63.82 | ||
40 | International Journal of Oncology | journal | 1.405 Q2 | 139 | 235 | 1092 | 14939 | 5449 | 1092 | 5.19 | 63.57 | |
41 | Best Practice and Research in Clinical Haematology | journal | 1.130 Q2 | 81 | 48 | 149 | 3011 | 463 | 141 | 2.92 | 62.73 | |
42 | Immuno-Oncology and Technology | journal | 10 | 11 | 13 | 685 | 23 | 10 | 1.77 | 62.27 | ||
43 | Gastric and Breast Cancer | journal | 0.101 Q4 | 6 | 11 | 34 | 673 | 0 | 34 | 0.00 | 61.18 | |
44 | Current Breast Cancer Reports | journal | 0.467 Q3 | 24 | 49 | 113 | 2996 | 147 | 113 | 0.95 | 61.14 | |
45 | npj Precision Oncology | journal | 36 | 33 | 61 | 2009 | 450 | 60 | 7.32 | 60.88 | ||
46 | Endocrine-Related Cancer | journal | 1.892 Q1 | 146 | 102 | 383 | 6194 | 2004 | 351 | 4.93 | 60.73 | |
47 | Experimental Hematology and Oncology | journal | 1.223 Q2 | 42 | 37 | 96 | 2219 | 372 | 95 | 4.33 | 59.97 | |
48 | Seminars in Oncology | journal | 1.812 Q1 | 145 | 50 | 150 | 2958 | 702 | 124 | 4.35 | 59.16 | |
49 | Current Opinion in HIV and AIDS | journal | 1.901 Q1 | 78 | 53 | 233 | 3130 | 940 | 223 | 3.90 | 59.06 | |
50 | Journal of Experimental and Clinical Cancer Research | journal | 2.752 Q1 | 120 | 252 | 904 | 14857 | 8592 | 904 | 9.79 | 58.96 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®